Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein.
We have demonstrated previously that the core protein of hepatitis C virus (HCV) exhibits suppression activity on gene expression and replication of hepatitis B virus (HBV). Here we further elucidated the suppression mechanism of HCV core protein. We demonstrated that HCV core protein retained the inhibitory effect on HBV gene expression and replication when expressed as part of the full length of HCV polyprotein. Based on the substitution mutational analysis, our results suggested that mutation introduced into the bipartite nuclear localization signal of the HCV core protein resulted in the cytoplasmic localization of core protein but did not affect its suppression ability on HBV gene expression. Mutational studies also indicated that almost all dibasic residue mutations within the N-terminal 101-amino acid segment of the HCV core protein (except Arg(39)-Arg(40)) impaired the suppression activity on HBV replication but not HBV gene expression. The integrity of Arg residues at positions 101, 113, 114, and 115 was found to be essential for both suppressive effects, whereas the Arg residue at position 104 was important only in the suppression of HBV gene expression. Moreover, our results indicated that the suppression on HBV gene expression was mediated through the direct interaction of HCV core protein with the trans-activator HBx protein, whereas the suppression of HBV replication involved the complex formation between HBV polymerase (pol) and the HCV core protein, resulting in the structural incompetence for the HBV pol to bind the package signal and consequently abolished the formation of the HBV virion. Altogether, this study suggests that these two suppression effects on HBV elicited by the HCV core protein likely depend on different structural context but not on nuclear localization of the core protein, and the two effects can be decoupled as revealed by its differential targets (HBx or HBV pol) on these two processes of the HBV life cycle.
Chen
Shiow-Yi
SY
Institute of Biochemistry and Institute of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan 112, Republic of China.
Kao
Chih-Fei
CF
Chen
Chun-Ming
CM
Shih
Chwen-Ming
CM
Hsu
Ming-Jen
MJ
Chao
Chi-Hong
CH
Wang
Shao-Hung
SH
You
Li-Ru
LR
Lee
Yan-Hwa Wu
YH
D000818:Animals; D001120:Arginine / Q000378:metabolism; D002213:Capsid / Q000378:metabolism; D015853:Cysteine Proteinase Inhibitors / Q000378:metabolism; D015967:Gene Expression Regulation, Viral; D015684:Gene Products, pol / Q000235:genetics / Q000378:metabolism; D006511:Hepatitis B Antigens / Q000235:genetics / Q000378:metabolism; D006515:Hepatitis B virus / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D046911:Macromolecular Substances; D016297:Mutagenesis, Site-Directed; D017434:Protein Structure, Tertiary; D012313:RNA / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D012097:Repressor Proteins / Q000235:genetics / Q000378:metabolism*; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism; D014407:Tumor Cells, Cultured; D014758:Viral Core Proteins / Q000235:genetics / Q000378:metabolism*; D017361:Viral Nonstructural Proteins / Q000235:genetics / Q000378:metabolism; D054334:Viral Regulatory and Accessory Proteins; D014779:Virus Replication
D015853:Cysteine Proteinase Inhibitors; D015684:Gene Products, pol; D006511:Hepatitis B Antigens; D046911:Macromolecular Substances; C066027:P protein, Hepatitis B virus; D011993:Recombinant Fusion Proteins; D012097:Repressor Proteins; D015534:Trans-Activators; D014758:Viral Core Proteins; D017361:Viral Nonstructural Proteins; D054334:Viral Regulatory and Accessory Proteins; C057628:hepatitis B virus X protein; C069130:nucleocapsid protein, Hepatitis C virus; D012313:RNA; D001120:Arginine